Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol. 1987

A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
Institute of Pharmacology, University of Ferrara, Department of Preclinical and Clinical Pharmacology, Italy.

We studied the electrophysiological effects of the specific beta 2-agonist tulobuterol in the guinea-pig sinus node and in sheep cardiac Purkinje fibers. Stimulation of beta 2-adrenoceptors by tulobuterol resulted in a slight increase in the rate of firing of the sinus node. In Purkinje fibers, however, automaticity was not affected up to concentrations of 10(-6) M. Consistently, tulobuterol (10(-8)-10(-6) M) did not affect the pacemaker current studied under voltage-clamp conditions. In the same range of concentrations (10(-8)-10(-6)M) tulobuterol dose-dependently increased the contractile force of driven Purkinje fibers. Tulobuterol, at a very high concentration (10(-5) M), had membrane depressant effects as demonstrated by the block of automaticity induced in the spontaneously beating Purkinje fibers and by the reduction of the maximum rate of depolarization in driven preparations. Our results suggest that stimulation of beta 2-adrenoceptors with tulobuterol in sheep Purkinje fibers is associated with an inotropic rather than a chronotropic effect. On the whole, the data confirm the lack of cardiac side effects of tulobuterol.

UI MeSH Term Description Entries
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D013726 Terbutaline A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. Arubendol,Asthmoprotect,Brethaire,Brethine,Bricanyl,Bricanyl SA,Butaliret,Butalitab,Contimit,KWD-2019,Monovent,Taziken,Tedipulmo,Terbasmin,Terbul,Terbutalin AL,Terbutalin Stada,Terbutalin-ratiopharm,Terbutaline Sulfate,Terbuturmant,terbutalin von ct,KWD 2019,KWD2019,Terbutalin ratiopharm

Related Publications

A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
August 1990, Journal of molecular and cellular cardiology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
July 1990, Journal of the autonomic nervous system,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
September 2009, British journal of pharmacology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
August 1991, Pharmacological research,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
January 2006, Pharmacology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
August 1992, European journal of pharmacology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
April 1986, The American journal of cardiology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
January 1994, Journal of investigational allergology & clinical immunology,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
April 1983, Clinical pharmacology and therapeutics,
A Mugelli, and S Amerini, and P De Bonfioli Cavalcabo, and E Cerbai, and S Visentin
April 1986, The American journal of cardiology,
Copied contents to your clipboard!